期刊文献+

肾上腺髓质素、内皮素与冠心病心功能关系的研究 被引量:3

The study of correlation between the plasma adrenomedullin,endothelin,and cardiac function in patients with coronary heart disease
下载PDF
导出
摘要 目的探讨不同类型的冠心病患者血浆肾上腺髓质素(ADM)和内皮素(ET1)水平,同时分析ADM及ET1含量与冠心病心功能的关系。方法30例正常人及79例冠心病患者,其中冠心病患者分为急性心肌梗死组(AMI组)38例和心绞痛组(AP组)41例,应用放射免疫法测定79例冠心病患者和30例正常对照者血浆ADM和ET1水平。结果冠心病2组血浆ADM和ET1均高于对照组(P<0.05);AMI组血浆ADM和ET1高于AP组(P<0.05);心力衰竭患者血浆ADM、ET1含量升高程度与心力衰竭严重程度相平行,心功能II级、III级、IV级之间差异均有显著意义(P<0.05)。结论ADM和ET1参与了冠心病及心力衰竭的病理生理过程,血浆ADM升高可能与ET1升高有关。 Objective To observe the changes of plasma adrenomedullin (ADM) and endothelin (ET-1) in patients with coronary heart disease and to study the correlation between ADM, ET-1 and cardiac function. Methods The plasma ADM and ET-1 were detected by radioimmunoassay in 79 patients with coronary heart disease who were divided into two groups(AMI group, n = 38;AP group, n =41) and compared with normal subjects (control group, n =30).Results The plasma ADM and ET-1 in patients with coronary heart disease were significantly higher than those in control group,the plasma ADM and ET-1 in AMI group were significantly higher than those in AP group ( P 〈 0. 05). The increase of plasma ADM and ET- 1 was closely related with the severity of heart failure. Conclusion ADM and ET-1 are involved in the process of pathophysiology in patients with coronary heart disease and heart failure. The elevated plasma ET-1 may be responsible for the increase of ADM in patients with coronary heart disease and heart failure.
出处 《疑难病杂志》 CAS 2006年第1期9-11,共3页 Chinese Journal of Difficult and Complicated Cases
关键词 肾上腺髓质素 内皮素 冠心病 心力衰竭 Adrenomedullin Endothelin Coronary heart disease Heart failure
  • 相关文献

参考文献7

  • 1Tian Q,Zhao D,Tan DY,et al.Hypotensive effects and mechanisms of adrenomedullin(13-25)[J].Chin J Hyper,1994,2:13.
  • 2Nagaya N,Nishikimi T,Uematsu M,et al.Plasma adrenomedullin as an indicator of prognosis after acute myocardial infarction[J].Heart,1999,81:483-487.
  • 3Miyao Y,Nishikimi T,Goto Y,et al.Increased plasma adrenomedullin levels in patients with acute myocardial infarction in proportion to the clinical severity[J].Heart,1998,79:39-44.
  • 4Jougasaki M,Rodeheffer RJ,Redfield MM,et al.Cardiac secretion of adrenomedullin in human heart failure[J].J Clin Invest,1996,97,2 370-2 376.
  • 5Nishikimi T,Yoshihara F,Mori Y,et al.Cardioprotective effect of adrenomedullin in heart failure[J].Hypertens Res,2003,26(Suppl):S121.
  • 6Etoh T,Kato J,Takenaga M,et al.Differential hormonal profile of adrenomedullin proadrenomedullin N-terminal 20 peptide in patients with heart failure and effects of treatment on their:plasma levels[J].Clin Cardiol,1999,22:113.
  • 7Oya H,Nagaya N,Furuichi S,et al.Compasion of intravenous adrenomedullin with atrial natriuretic peptide in patients with congestive heart failure[J].Am J Cardiol,2000,86:94.

同被引文献32

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部